Medtronic has received Japanese regulatory approval for its Sprint QuattroTM (Model 6944 and 6947) steroid-eluting right ventricular lead used with implantable cardioverter-defibrillators (ICDs) that detect and treat rapid and potentially lethal heart rhythms.
Medtronic said its Sprint Quattro 6947, with bipolar sensing and dual coil defibrillation, is Japan’s first 8.6 French defibrillation lead to feature screw-in fixation. Screw-in fixation offers flexibility in securing the ICD lead in various right ventricle locations.
The Sprint Quattro 6947 Screw-In ICD lead is used with various ICD and cardiac resynchronization therapy (CRT) devices, Medtronic said.
The company has now commercially launched its product in Japan.